BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 22209714)

  • 1. Hydrogen sulfide-releasing aspirin modulates xenobiotic metabolizing enzymes in vitro and in vivo.
    Chattopadhyay M; Kodela R; Nath N; Street CR; Velázquez-Martínez CA; Boring D; Kashfi K
    Biochem Pharmacol; 2012 Mar; 83(6):733-40. PubMed ID: 22209714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NO-donating aspirin induces phase II enzymes in vitro and in vivo.
    Gao J; Kashfi K; Liu X; Rigas B
    Carcinogenesis; 2006 Apr; 27(4):803-10. PubMed ID: 16267095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo.
    Chattopadhyay M; Kodela R; Nath N; Barsegian A; Boring D; Kashfi K
    Biochem Pharmacol; 2012 Mar; 83(6):723-32. PubMed ID: 22209867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: a general property and evidence of a tissue type-independent effect.
    Chattopadhyay M; Kodela R; Nath N; Dastagirzada YM; Velázquez-Martínez CA; Boring D; Kashfi K
    Biochem Pharmacol; 2012 Mar; 83(6):715-22. PubMed ID: 22222427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes.
    McMahon M; Itoh K; Yamamoto M; Chanas SA; Henderson CJ; McLellan LI; Wolf CR; Cavin C; Hayes JD
    Cancer Res; 2001 Apr; 61(8):3299-307. PubMed ID: 11309284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of NAD(P)H quinone: oxidoreductase1 inhibits carcinogen-induced aberrant crypt foci in colons of Sprague-Dawley rats.
    Begleiter A; Sivananthan K; Curphey TJ; Bird RP
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):566-72. PubMed ID: 12815004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of rat hepatic and kidney phase II enzymes by cabbage juices: comparison with the effects of indole-3-carbinol and phenethyl isothiocyanate.
    Krajka-Kuźniak V; Szaefer H; Bartoszek A; Baer-Dubowska W
    Br J Nutr; 2011 Mar; 105(6):816-26. PubMed ID: 21092375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regulation mechanism of triterpenoid components from Prunella asiatica on phase II detoxifying enzymes in vitro and in vivo].
    Jin P; Tan XB; Liu WB; Jia XB
    Zhongguo Zhong Yao Za Zhi; 2012 Dec; 37(23):3637-40. PubMed ID: 23477155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dietary genistein on Phase II and antioxidant enzymes in rat liver.
    Wiegand H; Wagner AE; Boesch-Saadatmandi C; Kruse HP; Kulling S; Rimbach G
    Cancer Genomics Proteomics; 2009; 6(2):85-92. PubMed ID: 19451092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of quercetin and catechin on hepatic glutathione-S transferase (GST), NAD(P)H quinone oxidoreductase 1 (NQO1), and antioxidant enzyme activity levels in rats.
    Wiegand H; Boesch-Saadatmandi C; Regos I; Treutter D; Wolffram S; Rimbach G
    Nutr Cancer; 2009; 61(5):717-22. PubMed ID: 19838946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of benzo[a]pyrene on tissue activities of metabolizing enzymes and antioxidant system in normal and protein-malnourished rats.
    Badary OA; AbdEl-Gawad HM; Taha RA; Ali AA; Hamada FM
    J Biochem Mol Toxicol; 2003; 17(2):86-91. PubMed ID: 12717740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II-selective induction of hepatic drug-metabolizing enzymes by oltipraz -5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione-, 1,7-phenanthroline, and 2,2'-dipyridyl in rats is not accompanied by induction of intestinal enzymes.
    Vargas M; Lamb JG; Franklin MR
    Drug Metab Dispos; 1998 Feb; 26(2):91-7. PubMed ID: 9456293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulation of the NAD(P)H:quinone oxidoreductase 1 and glutathione S-transferase ya genes by mercury, lead, and copper.
    Korashy HM; El-Kadi AO
    Drug Metab Dispos; 2006 Jan; 34(1):152-65. PubMed ID: 16243960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemopreventive and therapeutic modulation of green tea polyphenols on drug metabolizing enzymes in 4-Nitroquinoline 1-oxide induced oral cancer.
    Srinivasan P; Suchalatha S; Babu PV; Devi RS; Narayan S; Sabitha KE; Shyamala Devi CS
    Chem Biol Interact; 2008 Apr; 172(3):224-34. PubMed ID: 18336807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-dependent acetylsalicylic acid effects on liver CYP1A and antioxidant enzymes in a rat model of 7,12-dimethylbenzanthracene (DMBA)-induced mammary carcinogenesis.
    Girolami F; Abbadessa G; Racca S; Spaccamiglio A; Piccione F; Dacasto M; Carletti M; Gardini G; Di Carlo F; Nebbia C
    Toxicol Lett; 2008 Sep; 181(2):87-92. PubMed ID: 18678235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model.
    Chattopadhyay M; Kodela R; Olson KR; Kashfi K
    Biochem Biophys Res Commun; 2012 Mar; 419(3):523-8. PubMed ID: 22366248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemopreventive effects of Furan-2-yl-3-pyridin-2-yl-propenone against 7,12-dimethylbenz[a]anthracene-inducible genotoxicity.
    Hwang YP; Han EH; Choi JH; Kim HG; Lee KJ; Jeong TC; Lee ES; Jeong HG
    Toxicol Appl Pharmacol; 2008 May; 228(3):343-50. PubMed ID: 18255114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nrf2-mediated induction of detoxifying enzymes by alantolactone present in Inula helenium.
    Seo JY; Lim SS; Kim JR; Lim JS; Ha YR; Lee IA; Kim EJ; Park JH; Kim JS
    Phytother Res; 2008 Nov; 22(11):1500-5. PubMed ID: 18702092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular kinetics of induction by oltipraz and its keto derivative of detoxication enzymes in human colon adenocarcinoma cells.
    O'Dwyer PJ; Clayton M; Halbherr T; Myers CB; Yao Ks
    Clin Cancer Res; 1997 May; 3(5):783-91. PubMed ID: 9815750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic activation of heterocyclic amines and expression of CYP1A1 in the tongue.
    Takiguchi M; Darwish WS; Ikenaka Y; Ohno M; Ishizuka M
    Toxicol Sci; 2010 Jul; 116(1):79-91. PubMed ID: 20308224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.